LMNB2 Human Pre-designed siRNA Set A contains three designed siRNAs for LMNB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMO1 Human Pre-designed siRNA Set A contains three designed siRNAs for LMO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMO2 Human Pre-designed siRNA Set A contains three designed siRNAs for LMO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMO3 Human Pre-designed siRNA Set A contains three designed siRNAs for LMO3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMO4 Human Pre-designed siRNA Set A contains three designed siRNAs for LMO4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMO7 Human Pre-designed siRNA Set A contains three designed siRNAs for LMO7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMOD1 Human Pre-designed siRNA Set A contains three designed siRNAs for LMOD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMOD2 Human Pre-designed siRNA Set A contains three designed siRNAs for LMOD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMOD3 Human Pre-designed siRNA Set A contains three designed siRNAs for LMOD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMTK2 Human Pre-designed siRNA Set A contains three designed siRNAs for LMTK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMTK3 Human Pre-designed siRNA Set A contains three designed siRNAs for LMTK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMX1A Human Pre-designed siRNA Set A contains three designed siRNAs for LMX1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LMX1B Human Pre-designed siRNA Set A contains three designed siRNAs for LMX1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LNP1 Human Pre-designed siRNA Set A contains three designed siRNAs for LNP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LNPEP Human Pre-designed siRNA Set A contains three designed siRNAs for LNPEP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LNPK Human Pre-designed siRNA Set A contains three designed siRNAs for LNPK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LNX1 Human Pre-designed siRNA Set A contains three designed siRNAs for LNX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LNX2 Human Pre-designed siRNA Set A contains three designed siRNAs for LNX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lobophorin CR-2 is a lobophorin congener which induces UPR-associated gene expression, inhibits oral squamous cell carcinoma cell growth, and causes UPR-dependent cell death in MEF cells[1].

Lofemizole is a non-steroidal anti-inflammatory agent[1].

Loloatin B 10 is an antibiotic, which exhibits antibacterial efficacy against gram positive antibiotic resistant human pathogens[1].

Lomustine (Standard) is the analytical standard of Lomustine. This product is intended for research and analytical applications. Lomustine (CCNU; NSC 79037) is a DNA alkylating agent, with antitumor activity.

Longipedunin A is a HIV-1 Protease inhibitor with an IC50 value of 50 µg/mL[1].

LONP1 Human Pre-designed siRNA Set A contains three designed siRNAs for LONP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LONP2 Human Pre-designed siRNA Set A contains three designed siRNAs for LONP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LONRF2 Human Pre-designed siRNA Set A contains three designed siRNAs for LONRF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LONRF3 Human Pre-designed siRNA Set A contains three designed siRNAs for LONRF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lopinavir (Standard) is the analytical standard of Lopinavir. This product is intended for research and analytical applications. Lopinavir (ABT-378) is a highly potent, selective peptidomimetic inhibitor of the HIV-1 protease, with Kis of 1.3 to 3.6 pM for wild-type and mutant HIV protease. Lopinavir acts by arresting maturation of HIV-1 thereby blocking its infectivity[1][2]. Lopinavir […]

Lopinavir-d7 is deuterated labeled Lopinavir (HY-14588). Lopinavir (ABT-378) is a highly potent, selective peptidomimetic inhibitor of the HIV-1 protease, with Kis of 1.3 to 3.6 pM for wild-type and mutant HIV protease. Lopinavir acts by arresting maturation of HIV-1 thereby blocking its infectivity[1][2]. Lopinavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 14.2 […]

LORICRIN Human Pre-designed siRNA Set A contains three designed siRNAs for LORICRIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Losartan acid-d6 hydrochloride is deuterated labeled Losartan acid.

Losartan (potassium) (Standard) is the analytical standard of Losartan (potassium). This product is intended for research and analytical applications. Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.

Losartan-d6 hydrochloride is deuterated labeled Losartan potassium (HY-17512A). Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.

Low density lipoprotein (human) is one of the five major groups of lipoprotein that carries cholesterol to various tissues such as the adrenal gland, gonads, muscle, and adipose tissue[1].

LOX Human Pre-designed siRNA Set A contains three designed siRNAs for LOX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LOXHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for LOXHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LOXL1 Human Pre-designed siRNA Set A contains three designed siRNAs for LOXL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LOXL2 Human Pre-designed siRNA Set A contains three designed siRNAs for LOXL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LOXL3 Human Pre-designed siRNA Set A contains three designed siRNAs for LOXL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LOXL4 Human Pre-designed siRNA Set A contains three designed siRNAs for LOXL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lp-PLA2-IN-17 (Compound 39) is an inhibitor of Lp-PLA2. Lp-PLA2-IN-17 can be used to study disorders involving the hydrolysis of oxidized lipids into two inflammatory substances with the participation of Lp-PLA2[1].

LPA Human Pre-designed siRNA Set A contains three designed siRNAs for LPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPA5 antagonist 3 (Example 74) is a lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC50 of 170 nM. LPA5 antagonist 3 can be used for the research of pain disorders and atherosclerosis[1].

LPAR1 antagonist 1 (compound 18) is a potent, oral active and selective LPAR1 antagonist with the IC50 of 3.3 nM. LPAR1 antagonist 1 can be used for study of fibrosis[1].